5004122025-07-012025-09-305004122025-09-305004122025-03-315004122025-04-012025-09-305004122025-07-012025-09-30in-capmkt:OtherExpenses1Member5004122025-04-012025-09-30in-capmkt:OtherExpenses1Member5004122025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15004122025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25004122025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15004122025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25004122025-07-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss15004122025-07-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss25004122025-04-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss15004122025-04-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares500412TIRUMALCHMNOTLISTEDINE338A01024Thirumalai Chemicals LimitedMain BoardEquity2025-04-012026-03-312025-11-082025-11-04INRLakhsQuarterlySecond quarterSingle segmentChemical products and its intermediaries2025-11-0810:30:002025-11-0814:20:00trueCash Flow IndirectNot applicable2025-07-012025-09-30UnauditedConsolidated445370000083900000453760000038392000005600000-4413000002397000002572000002279000008470000004975300000-4377000000-4377000000-103900000-1039000000-3338000000000-333800000212600000-1212000001187000001-3.07-3.0700-3.07-3.071. The Audit Committee has reviewed and the Board of Directors have approved the above results at their respective meetings held on 07 November 2025 and 08 November 2025 respectively. The Statutory Auditors of the Company have carried out Limited Review of the aforesaid results. <BR> 2. In accordance with Ind AS 108, Operating Segments, the Group has identified manufacture and sale of organic chemicals as the only reportable segment. <BR> 3. The Standalone and Consolidated financial results have been prepared in accordance with recognition and measurement principles laid down in the Indian Accounting Standard 34, Interim financial reporting (Ind AS 34), prescribed under Section 133 of the Companies Act 2013, and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of the Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 as amended. <BR> 4. On 26 August 2025, the Company has allotted 1,62,68,040 equity shares of Rs.1/- each pursuant to a Preferential Issue as per the relevant provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 at a price of Rs. 277/- per share aggregating to Rs. 45,062 lakhs. <BR> 2025-04-012025-09-30UnauditedConsolidated895420000066600000902080000074914000008700000-431500000471900000439100000444300000167830000010102200000-10814000000-10814000000-148000000-1480000000-9334000000000-933400000307000000-6264000001187000001-8.84-8.8400-8.84-8.84Other Expenses847000000Other Expenses1678300000128074000001739830000009000001973500000054300000202780000027350000032507900000359200000012820000020478000001957000000161330000007620000058225000001099000001413100000109375000004344540000011870000015205300000153240000001532400000015557100000212220000017679300000151800000483800000426200000187411000004483600000715000003698800000377030000010034000009257300000677000005530000093803000002812140000043445400000439100000-1114100000-383000000-768000008980000025600000-901000000-4583000000-134000000444300000000-64880000000227000001010000000000-1127000000-1586500000-2667900000000166000000-26845000000001282000000000000000000000000000024900000134000000-3407100000-349700000000450620000000000976160000060458000006110000001982900000006178000000-350000013140000012790000018291000001957000000Re-measurements of defined benefit plans-7600000Equity instruments through other comprehensive income, net-159100000-166700000Re-measurements of defined benefit plans-7400000Equity instruments through other comprehensive income, net-22500000-29900000-25200000-5000000Exchange differences on translation of foreign operations363000000Cash flow hedge reserve-8900000354100000Exchange differences on translation of foreign operations360500000Cash flow hedge reserve-2860000033190000000212600000307000000